Clinical

Weekly Digest – August 2024 Weekly Digest – August 2024 07 Aug 2024: Invenra Highlights Exelixis’ Announcement: Initiation of Phase 1 Clinical Trial Evaluating XB010 in Patients with Advanced Solid Tumors Exelixis has started the dose-escalation stage of a Phase […]

by Sandhya Ramalingam

Continue Reading

Weekly Digest – August 2024 Weekly Digest – August 2024 07 Aug 2024: Exelixis drops tissue factor-targeting ADC after deciding it’s no match for Tivdak Exelixis has decided to discontinue development of its tissue factor-targeting antibody-drug conjugate, XB002, after assessing […]

by Sandhya Ramalingam

Continue Reading